{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:48:57Z","timestamp":1768391337206,"version":"3.49.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"\n Introduction<\/jats:title>\n The major neutrophilic peptide alpha-defensin plays a pivotal role in atherogenesis. Atherosclerosis is more frequent in dialysis patients, increasingly ascribed to chronic low-grade inflammation. We investigated the potential association between dialysis treatment and circulating alpha-defensin levels.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n In a cohort of hemodialysis (HD) patients, plasma alpha-defensin concentrations were determined immediately before and after a dialysis session. Blood samples were also tested for CBC, CRP, lipid profile, and troponin levels. Body weight change, Urea Reduction Ratio and Kt\/V were used to assess dialysis adequacy. Patients were divided into two groups based on alpha-defensin increase post dialysis. Groups were compared for dialysis adequacy, CBC, CRP, LDL levels, and the incidence of new documented coronary artery narrowing post HD initiation. The study was approved by the local IRB and all patients were consented.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 37 HD patients (55% males, median age 66.5 (60.3\u201378 years)) were recruited. There was a marked surge in median alpha-defensin levels after HD [11,571\n vs<\/jats:italic>\n . 16,661 ng\/ml, p=0.009]. Overall, alpha-defensin levels increased in 65% of cases, whereas CRP levels showed no significant rise following dialysis. Similarly, platelet and neutrophil counts exhibited no significant change. Kt\/V values were found favorable in HD patients with alpha-defensin decrease (1.48\n vs<\/jats:italic>\n . 1.37, P = 0.24), corresponding to a higher body weight decrease post dialysis (2.4%\n vs<\/jats:italic>\n . 1.75%). Moreover, the HD group with alpha-defensin increase was more prone to sustain new cardiovascular events (12.5%\n vs<\/jats:italic>\n . 0% at a median time of 5 (3.75-6.57) years), despite demonstrating a better blood lipid profile (LDL 63\n vs<\/jats:italic>\n . 87 mg\/dl).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n HD is an alpha-defensin generating procedure. Patients are potentially predisposed to atherosclerosis because of their enhanced alpha defensin secretion. alpha-defensin might evolve as a potential therapeutic target for atherosclerosis mitigation in this high-risk population. However, this remains to be validated in future research.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1718452","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:41:16Z","timestamp":1768372876000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory burden in dialysis patients: the role of alpha defensin"],"prefix":"10.3389","volume":"16","author":[{"given":"Maanit","family":"Shapira","sequence":"first","affiliation":[{"name":"Division of Laboratories, Hillel Yaffe Medical Center","place":["Hadera, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adib","family":"Abo Aqil","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hillel Yaffe Medical Center, Hadera, Israel, and the Ruth and Bruce Rappaport Faculty of Medicine","place":["Technion, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameena","family":"Zahalka","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hillel Yaffe Medical Center","place":["Hadera, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isis","family":"Abumouch","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hillel Yaffe Medical Center, Hadera, Israel, and the Ruth and Bruce Rappaport Faculty of Medicine","place":["Technion, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naama","family":"Amsalem","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hillel Yaffe Medical Center, Hadera, Israel, and the Ruth and Bruce Rappaport Faculty of Medicine","place":["Technion, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Abu Fanne","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hillel Yaffe Medical Center, Hadera, Israel, and the Ruth and Bruce Rappaport Faculty of Medicine","place":["Technion, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"lii","DOI":"10.1097\/01.MAT.0000147958.87989.EB","article-title":"Chronic systemic inflammation in dialysis patients: an update on causes and consequences","volume":"50","author":"Yao","year":"2004","journal-title":"ASAIO J (American Soc Artif Internal Organs: 1992)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.2002.00083.x","article-title":"Inflammation in end-stage renal disease: sources, consequences, and therapy","volume":"15","author":"Stenvinkel","year":"2002","journal-title":"Semin Dialysis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17788","DOI":"10.1038\/s41598-022-22474-9","article-title":"Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease","volume":"12","author":"Haim-Pinhas","year":"2022","journal-title":"Sci Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013501997","article-title":"Safety and efficacy of statins in patients with end-stage renal disease","volume":"47","author":"Nemerovski","year":"2013","journal-title":"Ann Pharmacother"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006080910","article-title":"Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients","volume":"17","author":"Zoccali","year":"2006","journal-title":"J Am Soc Nephrol: JASN"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp767","article-title":"Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study","volume":"25","author":"Cho","year":"2010","journal-title":"Nephrol Dial Transpl: Off Publ Eur Dialysis Transplant Assoc Eur Renal Assoc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00062752-200701000-00005","article-title":"Multispecific myeloid defensins","volume":"14","author":"Lehrer","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04640.x","article-title":"Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb\/IIIa","volume":"10","author":"Horn","year":"2012","journal-title":"J Thromb Haemost: JTH"},{"key":"B9","article-title":"The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis","volume":"96","author":"Higazi","year":"2000","journal-title":"Blood"},{"key":"B10","article-title":"Defensin promotes the binding of lipoprotein(a) to vascular matrix","volume":"94","author":"Bdeir","year":"1999","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1080","article-title":"Human alpha-defensin regulates smooth muscle cell contraction: a role for low-density lipoprotein receptor-related protein\/alpha 2-macroglobulin receptor","volume":"100","author":"Nassar","year":"2002","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2005.10.019","article-title":"Neutrophil antimicrobial peptide alpha-defensin causes endothelial dysfunction in porcine coronary arteries","volume":"43","author":"Kougias","year":"2006","journal-title":"J Vasc Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.30.17650","article-title":"Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells","volume":"271","author":"Higazi","year":"1996","journal-title":"J Biol Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.12.4290","article-title":"Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells","volume":"89","author":"Higazi","year":"1997","journal-title":"Blood"},{"key":"B15","article-title":"Immunohistochemical localization of defensin in human coronary vessels","volume":"150","author":"Barnathan","year":"1997","journal-title":"Am J Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.669812","article-title":"\u03b1-defensins induce a post-translational modification of low density lipoprotein (LDL) that promotes atherosclerosis at normal levels of plasma cholesterol","volume":"291","author":"Abu-Fanne","year":"2016","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-861237","article-title":"Neutrophil \u03b1-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability","volume":"133","author":"Abu-Fanne","year":"2019","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5551\/jat.10108","article-title":"Acute ST-segment elevation myocardial infarction is associated with decreased human antimicrobial peptide LL-37 and increased human neutrophil peptide-1 to 3 in plasma","volume":"19","author":"Zhao","year":"2012","journal-title":"J Atheroscl Thromb"},{"key":"B19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijcard.2011.03.030","article-title":"Markers of inflammation in relation to long-term cardiovascular mortality in patients with lower-extremity peripheral arterial disease","volume":"160","author":"Urbonaviciene","year":"2012","journal-title":"Int J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs021","article-title":"\u03b1-Defensins and outcome in patients with chronic heart failure","volume":"14","author":"Christensen","year":"2012","journal-title":"Eur J Heart Failure"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12121","article-title":"Impaired immune defense in hemodialysis patients: role of \u03b1-defensins","volume":"18","author":"Grupp","year":"2014","journal-title":"Hemodialysis Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000534447","article-title":"Chronic inflammation in chronic kidney disease","volume":"148","author":"Yan","year":"2024","journal-title":"Nephron"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.07.010","article-title":"Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study","volume":"64","author":"Banerjee","year":"2014","journal-title":"Am J Kidney Dis: Off J Natl Kidney Foundation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq273","article-title":"Variations in C-reactive protein during a single haemodialysis session do not associate with mortality","volume":"25","author":"Meuwese","year":"2010","journal-title":"Nephrol Dial Transpl: Off Publ Eur Dialysis Transplant Assoc Eur Renal Assoc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2002.kid556.x","article-title":"Inflammatory signals associated with hemodialysis","volume":"62","author":"Caglar","year":"2002","journal-title":"Kidney Int"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001865","article-title":"Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction","volume":"70","author":"Friedrich","year":"2006","journal-title":"Kidney Int"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ndt\/8.supp2.8","article-title":"Behaviour of white blood cells and the complement system","author":"Falkenhagen","year":"1993","journal-title":"Nephrol Dial Transpl: Off Publ Eur Dialysis Transplant Assoc Eur Renal Assoc"},{"key":"B29","article-title":"Response of complement and neutrophils to hydrophilized synthetic membranes","volume":"34","author":"Ward","year":"1988","journal-title":"ASAIO Trans"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.59780048.x","article-title":"Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils","volume":"78","author":"Cohen","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010060641","article-title":"MCP-1 gene activation marks acute kidney injury","volume":"22","author":"Munshi","year":"2011","journal-title":"J Am Soc Nephrol: JASN"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1718452\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:41:20Z","timestamp":1768372880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1718452\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2025.1718452"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1718452","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1718452"}}